Policymakers often face the challenging task of weighing the costs of new policies against their potential economic, environmental and health benefits. In this context, cost-benefit analysis and econ
Organisation for Economic Co-operation and Development40
Historically, there has been a lack of cost-effectiveness data regarding the inclusion of universal non-invasive prenatal testing (NIPT) for trisomy 21, 18, and 13 in the benefit package of the Univer
In what follows we provide a conceptually correct procedure for determining whether a risky project passes the "potential Pareto improvement" welfare criterion which forms the normative basis of cost-
